OFS (OFS Capital Corporation) Receives $52.3 Million From Pfanstiehl Stake
View the OFS Dividend Stock Profile
OFS Capital disclosed on October 6, 2026 that it received approximately ﹩52.3 million of gross proceeds from a transaction completed October 5. A new investor acquired 56.62% of the limited partnership interests in OFS SBIC I, LP, the subsidiary holding OFS’s large equity investment in pharmaceutical-ingredient manufacturer Pfanstiehl Holdings.
Cash released from a concentrated investment
The SEC filing gives the consideration precisely as ﹩52,279,500. The money was paid to the partnership and distributed in full to OFS. Fees, expenses and other transaction costs reduce the amount available for subsequent use. OFS intends to deploy the net proceeds into debt and equity investments and other general corporate purposes.
The partnership owns 400 Class A shares of Pfanstiehl. At June 30, that investment represented approximately 84% of OFS’s net assets and 31.8% of its total investments measured at fair value. These percentages use different denominators: net assets are what remains after liabilities, while total investments describe the investment portfolio before that subtraction.
OFS retains approximately 43.38% of the partnership interests, calculated from the disclosed percentage sold. Its wholly owned general partner also retains sole authority over the partnership’s business, investments and policies. Selling most of the economic interest therefore does not mean OFS has surrendered management control, nor does it mean OFS has exited Pfanstiehl entirely.
The earlier July 30 results provide relevant context. OFS attributed ﹩14.1 million of second-quarter unrealized appreciation to its Pfanstiehl common equity investment. That was an increase in estimated investment value, rather than cash received from a sale. The new transaction converts part of the exposure into cash, but its gross proceeds should not be presented as a ﹩52.3 million profit.
Fly High commentary
The economic opportunity is to convert a large equity position into a broader set of assets that can produce recurring investment income. Equity appreciation can strengthen asset value without providing regular interest payments. Loans can generate contractual interest, but the benefit depends on when OFS deploys the proceeds, the rates earned, borrower performance and the costs of managing and financing those assets.
Reducing concentration can also limit the effect that one company’s valuation changes have on OFS’s asset base. The trade-off is that OFS gives up part of Pfanstiehl’s future appreciation and any future distributions associated with the sold interest. Retaining control does not restore those sold economic rights.
For income investors, the important test is the subsequent change in recurring earnings available to support distributions. Neither sale proceeds nor an unrealized gain establishes that support. This announcement does not provide the comparable actual and independent forecast earnings needed for a formal Fly High Dividend Coverage Ratio, so no new coverage conclusion follows from the transaction alone.
Watch the next financial report for net proceeds after costs, the realized accounting result, the valuation of the retained interest and the pace of reinvestment. Credit losses or slow deployment could offset the expected income benefit. OFS’s retained exposure also means Pfanstiehl remains a meaningful investment risk even after this substantial monetization.
Sources
This article is general information, not personalized investment advice. Fly High Investing may hold securities discussed in this article.